239 related articles for article (PubMed ID: 15887963)
1. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.
Silber K; Heidler P; Kurz T; Klebe G
J Med Chem; 2005 May; 48(10):3547-63. PubMed ID: 15887963
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.
Mac Sweeney A; Lange R; Fernandes RP; Schulz H; Dale GE; Douangamath A; Proteau PJ; Oefner C
J Mol Biol; 2005 Jan; 345(1):115-27. PubMed ID: 15567415
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
[TBL] [Abstract][Full Text] [Related]
4. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
[TBL] [Abstract][Full Text] [Related]
5. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of phosphonated N-heteroarylcarboxamides as DOXP-reductoisomerase (DXR) inhibitors.
Bodill T; Conibear AC; Blatch GL; Lobb KA; Kaye PT
Bioorg Med Chem; 2011 Feb; 19(3):1321-7. PubMed ID: 21216609
[TBL] [Abstract][Full Text] [Related]
7. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-phosphate reductoisomerase complexes.
Yajima S; Hara K; Sanders JM; Yin F; Ohsawa K; Wiesner J; Jomaa H; Oldfield E
J Am Chem Soc; 2004 Sep; 126(35):10824-5. PubMed ID: 15339150
[TBL] [Abstract][Full Text] [Related]
9. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
[TBL] [Abstract][Full Text] [Related]
10. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
Proteau PJ
Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase from the hyperthermophile Thermotoga maritima for insights into the coordination of conformational changes and an inhibitor binding.
Takenoya M; Ohtaki A; Noguchi K; Endo K; Sasaki Y; Ohsawa K; Yajima S; Yohda M
J Struct Biol; 2010 Jun; 170(3):532-9. PubMed ID: 20353826
[TBL] [Abstract][Full Text] [Related]
13. Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
Phaosiri C; Proteau PJ
Bioorg Med Chem Lett; 2004 Nov; 14(21):5309-12. PubMed ID: 15454217
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Woo YH; Fernandes RP; Proteau PJ
Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
[TBL] [Abstract][Full Text] [Related]
15. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
Ortmann R; Wiesner J; Silber K; Klebe G; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Sep; 340(9):483-90. PubMed ID: 17806130
[TBL] [Abstract][Full Text] [Related]
16. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Deng L; Sundriyal S; Rubio V; Shi ZZ; Song Y
J Med Chem; 2009 Nov; 52(21):6539-42. PubMed ID: 19888756
[TBL] [Abstract][Full Text] [Related]
17. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: structural variations around phosphonate anchor and spacer of fosmidomycin, a potent inhibitor of deoxyxylulose phosphate reductoisomerase.
Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
J Org Chem; 2010 May; 75(10):3203-7. PubMed ID: 20429517
[TBL] [Abstract][Full Text] [Related]
18. NMR studies of DOXP reductoisomerase and its inhibitor complex.
Englert NE; Richter C; Wiesner J; Hintz M; Jomaa H; Schwalbe H
Chembiochem; 2011 Feb; 12(3):468-76. PubMed ID: 21290548
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
Devreux V; Wiesner J; Goeman JL; Van der Eycken J; Jomaa H; Van Calenbergh S
J Med Chem; 2006 Apr; 49(8):2656-60. PubMed ID: 16610809
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates.
Cheng F; Oldfield E
J Med Chem; 2004 Oct; 47(21):5149-58. PubMed ID: 15456258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
